Myogenes News & Blog
Welcome to the Myogenes Blog. Get the latest pharmacogenomics, DNA testing and genetics news.
Treatment Resistant Depression: What Is It?
According to the World Health Organisation, depression is the leading cause of disability in the world. According to estimates from the NHS, 264 million people worldwide suffer from depression, and 1 in 4 people in England will experience some form of mental health...
How treatment for ADHD can be personalised with genetic testing
After watching your child struggle for months to sit still or maintain focus, it can be a relief to hear that your child has attention-deficit/hyperactivity disorder (ADHD). You may have a few more hurdles to jump if your child's clinician recommends ADHD medication....
Pharmacogenomic Testing:
What is it and who should get it?
Recent decades have seen a rise in precision (or personalised) medicine due to rapid advances in genetics and a better understanding of the human brain and body. There is no guarantee that two people will respond to the same medication, even if they have similar...
Myogenes partners with Pink Ribbon Foundation
We’re incredibly proud to announce that we have officially partnered up with Pink Ribbon Foundation to help raise awareness of breast cancer and its early detection and treatment.? We believe there’s no place for guesswork in modern medicine. That’s why the experts...
Matching drugs to DNA is ‘new era of medicine’
We have the technology to start a new era in medicine by precisely matching drugs to people’s genetic code, a major report says. Some drugs are completely ineffective or become deadly because of subtle differences in how our bodies function. The British...
Experts push genetic testing for drug prescriptions
Pharmacogenomic testing could save the NHS money in the long term and reduce the risks of side-effects. Genetic testing to predict how individuals will respond to common medicines should be implemented without delay to reduce the risk of side-effects and ensure that...
Personalised Healthcare For All
Speak to one of our advisors today